A - Human Necessities – 61 – M
Patent
A - Human Necessities
61
M
A61M 15/00 (2006.01) C01B 21/22 (2006.01)
Patent
CA 2576957
Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. A nitric oxide delivery system that converts nitrogen dioxide to nitric oxide employs a surface-active material, such as silica gel, coated with an aqueous solution of antioxidant, such as ascorbic acid.
L'inhalation de faibles taux de monoxyde d'azote peut entraîner une chute rapide, sans risque, de l'hypertension artérielle pulmonaire chez les mammifères. Un système d'administration de monoxyde d'azote qui convertit du dioxyde d'azote en monoxyde d'azote utilise un matériau tensioactif, tel que du gel de silice, revêtu d'une solution aqueuse d'un antioxydant tel que l'acide ascorbique.
Fine David H.
Rounbehler David R.
Geno Llc
Smart & Biggar
LandOfFree
Conversion of nitrogen dioxide (no2) to nitric oxide (no) does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Conversion of nitrogen dioxide (no2) to nitric oxide (no), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Conversion of nitrogen dioxide (no2) to nitric oxide (no) will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2049452